Same Indication

Imatinib vs Montelukast

Imatinib vs Montelukast: Overview

This comparison examines the pharmacological differences between Imatinib and Montelukast.

Mechanism of Action

Imatinib: Selective inhibitor of BCR-ABL, c-Kit, and PDGFR tyrosine kinases.

Montelukast: Selective leukotriene D4 receptor antagonist.

Pharmacokinetics

Half-life: Imatinib β€” 18 hours; Montelukast β€” 2.7-5.5 hours.

Chemical Properties

Molecular Formula: Imatinib β€” C29H31N7O; Montelukast β€” C35H36ClNO3S.

Molecular Weight: Imatinib β€” 493.6030 g/mol; Montelukast β€” 586.1800 g/mol.

Type: Imatinib β€” Small molecule; Montelukast β€” Small molecule.